Fritze D, Kern D H, Drogemuller C R, Pilch Y H
Transplantation. 1975 Sep;20(3):211-8. doi: 10.1097/00007890-197509000-00005.
A rapid microcytotoxicity assay for the detection of HL-A antigens on tissue culture cells derived from human solid tumors is described. Tumor cells were prelabeled with 125Iododeoxyuridine. Isotopically labeled tumor cells were reacted with up to 37 highly selected HL-A antisera and diluted rabbit complement. Results of the HL-A typing of nine human tumor cell lines are reported. Three melanoma cell lines showed individually distinct HL-A profiles at the first HL-A locus which agreed with the antigenic pattern of the tumor donor's autologous lymphocytes. Less reactivity was noted with HL-A antisera defining second locus specificities on the three melanoma cell lines, whereas some other cell lines showed more HL-A reactions than required to present a "full house". This method obviates the necessity for visually enumerating residual tumor target cells.
本文描述了一种用于检测源自人类实体瘤的组织培养细胞上HL - A抗原的快速微量细胞毒性测定法。肿瘤细胞用125碘脱氧尿苷进行预标记。同位素标记的肿瘤细胞与多达37种高度选择的HL - A抗血清和稀释的兔补体反应。报告了九种人类肿瘤细胞系的HL - A分型结果。三种黑色素瘤细胞系在第一个HL - A位点分别显示出独特的HL - A谱型,这与肿瘤供体自体淋巴细胞的抗原模式一致。在三种黑色素瘤细胞系上,定义第二个位点特异性的HL - A抗血清的反应性较低,而其他一些细胞系显示出比呈现“全套”所需更多的HL - A反应。该方法消除了目视计数残留肿瘤靶细胞的必要性。